Persistent Fatigue Induced by Interferon-alpha: A New Immunological Model for Chronic Fatigue Syndrome

Lead Research Organisation: King's College London
Department Name: Psychological Medicine

Abstract

Chronic fatigue syndrome (CFS) is a medical condition in which patients feel persistently and overwhelmingly tired and run down, both physically and mentally. In addition, they have difficulty with concentration, flu-like symptoms and aches and pains. This condition interferes with daily life activity, and, in some patients, is profoundly disabling. Although many years of research have been conduced on CFS, we still do not know what is causing it.

One biological system that is involved in CFS is the "immune system", that is, the system dedicated to fight infections in our body. Indeed, in many cases CFS is triggered by an infection, but then the symptoms continue even after the infection has been eliminated. Specifically, infections are always accompanied by acute fatigue and flu-like symptoms, as a consequence of the infection-driven immune activation; however, in patients with CFS the immune activation and the associated fatigue and flu-like symptoms persist for months or years. Moreover, there is evidence that the immune system is in a state of "hyper-activity" in patients with CFS, as if they were fighting an infective agent, even though they do not have an ongoing infection.

This project aims to understand exactly this process: how the infection and the acute immune activation evolve into CFS, and what are the risk factors that make this process occur in some individuals but not others. Clearly, trying to study this process in subjects experiencing naturally-acquired infections is very difficult, for the unpredictability of these events. In contrast, we want to model the development of CFS by studying a group of patients that have a pre-existing infection (chronic viral hepatitis C, HCV) and that receive a course of treatment (lasting months) with the immune activator, interferon-alpha (IFN-alpha). IFN-alpha is the treatment of choice for HCV infection. Because it activates the immune system, IFN-alpha also induces fatigue and flu-like symptoms in all patients. Moreover, and of particular relevance for this study, a considerable proportion of patients continue to experience debilitating persistent fatigue, and other symptoms that are similar to CFS, for 6 months or even one year after the cessation of IFN-alpha. This phenomenon strikingly resembles CFS, which, as mentioned above, also persists after the infective/immune trigger has been eliminated. Therefore, we are proposing to use IFN-alpha as a model to understand how an immune trigger induces persistent fatigue even when the initial immune trigger is no longer present.

To do this, we will assess these patients throughout the many months of IFN-alpha treatment and at 6 months after cessation of treatment, in order to identify those with persistent "post-IFN-alpha-treatment" fatigue, and understand what biological and clinical changes lead to this outcome. Moreover, we will compare these patients with a group of patients with CFS and with a group of healthy individuals, conducting the same biological and clinical assessment. We will measure changes occurring in blood hormones that are relevant to the immune function, such as "cytokines" and "cortisol". In addition, we will asses changes in measures of well-being, including physical fitness, concentration, sleep and mood.

We are confident that creating and validating this model of CFS will generate a host of future studies aimed at improving the health of people with CFS. For example, we will be able to build a check-list of blood measures that could predict who will, and who will not, develop CFS; we will test novel treatments for "post-IFN-alpha-treatment" fatigue, facilitated by the fact that these patients are homogeneous in their clinical background, and then extend these treatments to patients with CFS; and, finally, we will truly understand what happens in the body during the development of CFS, and thus identify novel therapeutic approaches to interrupt this development.

Technical Summary

We propose to model chronic fatigue syndrome (CFS) by studying patients taking interferon-alpha (IFN-alpha) for chronic viral hepatitis C (HCV) infection. IFN-alpha treatment leads to acute fatigue in the majority of patients. Most importantly, a proportion of patients continue to experience persistent fatigue, together with other CFS-like-symptoms, for many months after the cessation of treatment, that is, in the absence of the pro-inflammatory stimulus. This phenomenon strikingly resembles CFS, which also persists after the viral/immune trigger has been eliminated.

In order to develop this as a model of CFS, in our three-year project we want to:
1) assess a cohort (n=100) of patients throughout the IFN-alpha treatment and at 6 months after cessation of treatment, and identify the group who develop the persistent post-treatment fatigue (expected n=50);
2) validate this model, by comparing the clinical and biomarkers profiles in patients who experience persistent post-treatment fatigue, patients with CFS (n=50), and healthy controls (n=50);
3) identify the risk factors and the biomarkers trajectories (before and during IFN-alpha treatment) that identify those patients who will later experience persistent post-treatment fatigue.

We will measure: fatigue, mood, and other CFS-like symptoms; medical and psychiatric history; childhood and recent stressors; social support; illness and treatment perceptions; physical fitness; quality of life; and occupational function. Moreover, we will measure blood biomarkers: serum cytokines; cortisol at awakening and during the day; and leukocytes gene expression.

The project will build onto an existing pilot study in HCV patients, an established collaboration with Liver Units across London, and the research-led clinical service for CFS patients at King's College Hospital. Thus, the project has great chances of success.

Planned Impact

Our research on chronic fatigue syndrome (CFS) will benefit health and biological scientists; policy makers; stakeholders in health care; the interested lay public (especially those with a personal investment in understanding CFS), and, finally, patients with CFS.

Social and health scientists will benefit from our data: we will explain the mechanisms underlying the development of chronic fatigue, offer novel aetiological hypotheses to be confirmed in CFS patients, identify a group who are particularly indicated to test novel therapeutic interventions, and suggest new potential biological targets for the pharmacological treatment of CFS.

Policy makers will benefit from the evidence offered by our study: it will guide them in prioritising resources, in the difficult times ahead, by identifying important stages in the development of chronic fatigues and hence where and when to deliver screening and intervention programmes.

Stakeholders will benefit from understanding what happens to people while they are developing chronic fatigue: charities, non-governmental organisations, and regulatory bodies, all aimed at improving the clinical and social outcomes of CFS patients, will want to know how health, well-being, quality of life and occupational functioning is impacted by changes in biology and behaviour, and how these people can thus be helped.

Finally, the lay public, and especially patients and carers who have been personally touched by CFS, will benefit from all of our work: a non-stigmatising approach based on a sound biological basis, and an explanatory model that is not deterministic and that emphasises not only risk factors but also the protective factors that could be sought out.

Publications

10 25 50

publication icon
Aiello G (2012) Citizen, interrupted: the 2011 English riots from a psychosocial perspective in Epidemiology and Psychiatric Sciences

publication icon
Alboni S (2013) N-acetyl-cysteine prevents toxic oxidative effects induced by IFN-a in human neurons. in The international journal of neuropsychopharmacology

publication icon
Amasi-Hartoonian N (2022) Understanding treatment-resistant depression using "omics" techniques: A systematic review. in Journal of affective disorders

publication icon
Anacker C (2013) Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

 
Title For all sad words 
Description Developed in collaboration with Prof Carmine Pariante, this work is a metaphorical blood exchange. It draws from Prof Pariante's research at King's College on blood inflammation in patients with depression, Stanford University's studies that show transfusion of young blood in old mice reversed aging, and Lund University's proposition that a protein found in beetroot (incidentally an anti-inflammatory food) could substitute human blood. The artist, Lynn Lu, invited participants to tell her about a significant personal regret. Then she pricked their finger and place a drop of blood in a petri dish. In exchange, she offers them a shot of anti-inflammatory beet juice. Over the weekend, the petri dishes fill with blood "inflamed" with lament, while vials of detoxifying beetroot empty one by one. 
Type Of Art Performance (Music, Dance, Drama, etc) 
Year Produced 2017 
Impact Engagement with the Science Gallery and other artistic organisation interested in using art to disseminate science 
URL https://lynnlu.info/for-of-all-sad-words-of-tongue-and-pen-the-saddest-are-these-it-might-have-been/...
 
Title Recording for live performance of artist Lynn Lu 
Description Drawing deeply from her personal experience, the artist Lynn Lu has spent some time during the development process of a performance for the CCLAP Festival with Professor Carmine Pariante, and his team at King's College London. Their research has found a clear link between mothers with postnatal depression not adequately nurturing their children and these children in time becoming themselves mothers who suffer from postnatal depression. At Deptford Lounge, the artist will create a safe space, one that she would have liked to have had, as a mother with postnatal depression. This safe space is offered to all mothers, as well as for anyone who might need an experience of nurturing. Together the artist and participants will put in words their darkest thoughts and feelings that have not been voiced. The anonymous texts will then be sealed in palm-sized clay envelops, and fired for strength / privacy / resilience. These accumulating tablets will be exhibited throughout the week. Participants will be invited to be cocooned and rocked in a wide fabric hammock for as long as they wish - as if in the womb, or a rockabye baby. In doing so, they will listen to a RECORDING OF THE INTERVIEW BETWEEN PROFESSOR PARIANTE AND THE ARTIST, which has been digitally modified so to make the words unintelligeble and similar to relaxing music. This performance will take place at Deptford Lounge. Full schedule for CCLAP 2015. 
Type Of Art Performance (Music, Dance, Drama, etc) 
Year Produced 2015 
Impact The recording was used in the performance, as above, so was publicly used. 
URL http://cclap.me/2015/10/26/cclap-2015-lynn-lu-the-hand-that-rocks-the-cradle/
 
Title The London Riots, a Psychiatrist's Perspective 
Description A blog on the 2012 London Riots. In 2012, one year after the London riots, I wrote a blog for the Huffington Post UK, and longer academic paper, where I tried to interpret the terrible events of 2011 London's burning through a psychosocial perspective. As you will read in the blog, republished below, I lamented that, one year on at that time, there had been no attempt to understand the youth's suffering that had led to the protest, and that all the events were brushed under the carpet as a public order problem. Unfortunately, 10 years on and the situation has not changed: lessons have still not been learned, and there is a clear concern that the same factors operating then can make the same events happen again today. 
Type Of Art Creative Writing 
Year Produced 2021 
Impact Impact on the knowledge of the public 
URL https://www.inspirethemind.org/blog/the-london-riots-a-psychiatrists-perspective?rq=pariante
 
Description 2013 CMO Report on Mental Health - Chapter on Neuroscience
Geographic Reach National 
Policy Influence Type Implementation circular/rapid advice/letter to e.g. Ministry of Health
Impact Improved understanding of neuroscience issues relevant to mental health
 
Description Inspire the Mind - a digital mental health magazine
Geographic Reach Multiple continents/international 
Policy Influence Type Influenced training of practitioners or researchers
Impact Our digital magazine aims to reduce stigma on mental health We have reached >250K people so far, we have an average of 10K readers per month in the last months We have published >500 articles often by new and aspiring writers in science or with lived experience of mental health problems
URL https://www.inspirethemind.org/
 
Description Lead of a new consensus statement on treatment resistant depression
Geographic Reach Multiple continents/international 
Policy Influence Type Membership of a guideline committee
 
Description Office for Clinical External Affairs of the British Association for Psychopharmacology
Geographic Reach National 
Policy Influence Type Contribution to a national consultation/review
 
Description Biomedical Research Centre - Affective Disorder and Interface with Medicine Theme
Amount £50,000,000 (GBP)
Funding ID NIHR Biomedical Research Centre at the South London and Maudsley NHS Trust and King's College London 
Organisation National Institute for Health Research 
Department NIHR Biomedical Research Centre
Sector Public
Country United Kingdom
Start 03/2017 
End 03/2022
 
Description Causative mechanisms & integrative models linking early-life-stress to psycho-cardio-metabolic multi-morbidity EC - European Commission
Amount € 6,000,000 (EUR)
Funding ID Earlycause 
Organisation European Commission H2020 
Sector Public
Country Belgium
Start 12/2019 
End 12/2023
 
Description Distinguished Investigator Award
Amount $100,000 (USD)
Organisation Brain & Behaviour Research Foundation 
Sector Charity/Non Profit
Country United States
Start 06/2018 
End 06/2019
 
Description Does COVID-19 affect the brain?
Amount £25,000 (GBP)
Funding ID M970 
Organisation Rosetrees Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 02/2021 
End 02/2022
 
Description MRC Immunopsychiatry consortium
Amount £200,000 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 09/2014 
End 09/2016
 
Description NIHR Senior Investigator
Amount £45,000 (GBP)
Funding ID NF-SI-0616-10074 
Organisation National Institute for Health Research 
Sector Public
Country United Kingdom
Start 03/2017 
End 03/2020
 
Description Professor, Carmine M. Pariante
Amount £100,000 (GBP)
Funding ID NIHR201376 
Organisation National Institute for Health Research 
Sector Public
Country United Kingdom
Start 03/2020 
End 03/2025
 
Description The Impact of Early Adversity on Trajectories of Brain Maturation and Mental Health in Young Adolescents
Amount £100,144 (GBP)
Funding ID MR/S003444/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 09/2018 
End 09/2022
 
Description Understanding the role of gender, inflammation and sex hormones in the prevention and treatment of affective disorders Psychiatry Research Trust
Amount £83,444 (GBP)
Funding ID Psychiatry Research Trust 
Organisation King's College London 
Department Psychiatry Research Trust
Sector Charity/Non Profit
Country United Kingdom
Start 09/2018 
End 09/2021
 
Description WHAT ARE THE IMMUNE SYSTEM RISK FACTORS FOR DEVELOPING CHRONIC POST-VIRAL FATIGUE FOLLOWING SARS-COV
Amount £99,998 (GBP)
Funding ID KENN192010 
Organisation The Kennedy Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 04/2020 
End 11/2021
 
Description Wellcome Trust Neuroimmunology Consortium
Amount £1,100,000 (GBP)
Organisation Wellcome Trust 
Department Wellcome Trust Institutional Strategic Support Fund
Sector Charity/Non Profit
Country United Kingdom
Start 01/2015 
End 12/2019
 
Title Genes list for depression 
Description The genes list obtained by transcriptomics of blood MRNA of patients with depression before and after antidepressant (GENDEP sample) and before and after interferon-alpha treatment (MRC-funded project), both as raw data and as combined gene lists with statistical enrichment for overlapping genes. 
Type Of Material Database/Collection of data 
Year Produced 2016 
Provided To Others? Yes  
Impact collaboration and cross validation across independent research groups 
 
Description ASPIRE - ADVANCED STRATIFICATION OF PEOPLE WITH DEPRESSION BASED ON INFLAMMATION 
Organisation Amsterdam Medical Center
Country Netherlands 
Sector Hospitals 
PI Contribution A consotium brought together to apply to the Wellcome trust for a programme of research
Collaborator Contribution They are all workpackage leaders, co-applicants or collaborators.
Impact Successful award of the grant
Start Year 2023
 
Description ASPIRE - ADVANCED STRATIFICATION OF PEOPLE WITH DEPRESSION BASED ON INFLAMMATION 
Organisation Cardiff University
Country United Kingdom 
Sector Academic/University 
PI Contribution A consotium brought together to apply to the Wellcome trust for a programme of research
Collaborator Contribution They are all workpackage leaders, co-applicants or collaborators.
Impact Successful award of the grant
Start Year 2023
 
Description ASPIRE - ADVANCED STRATIFICATION OF PEOPLE WITH DEPRESSION BASED ON INFLAMMATION 
Organisation Charité - University of Medicine Berlin
Country Germany 
Sector Academic/University 
PI Contribution A consotium brought together to apply to the Wellcome trust for a programme of research
Collaborator Contribution They are all workpackage leaders, co-applicants or collaborators.
Impact Successful award of the grant
Start Year 2023
 
Description ASPIRE - ADVANCED STRATIFICATION OF PEOPLE WITH DEPRESSION BASED ON INFLAMMATION 
Organisation Deakin University
Country Australia 
Sector Academic/University 
PI Contribution A consotium brought together to apply to the Wellcome trust for a programme of research
Collaborator Contribution They are all workpackage leaders, co-applicants or collaborators.
Impact Successful award of the grant
Start Year 2023
 
Description ASPIRE - ADVANCED STRATIFICATION OF PEOPLE WITH DEPRESSION BASED ON INFLAMMATION 
Organisation Emory University
Country United States 
Sector Academic/University 
PI Contribution A consotium brought together to apply to the Wellcome trust for a programme of research
Collaborator Contribution They are all workpackage leaders, co-applicants or collaborators.
Impact Successful award of the grant
Start Year 2023
 
Description ASPIRE - ADVANCED STRATIFICATION OF PEOPLE WITH DEPRESSION BASED ON INFLAMMATION 
Organisation National Institute of Health and Medical Research (INSERM)
Country France 
Sector Academic/University 
PI Contribution A consotium brought together to apply to the Wellcome trust for a programme of research
Collaborator Contribution They are all workpackage leaders, co-applicants or collaborators.
Impact Successful award of the grant
Start Year 2023
 
Description ASPIRE - ADVANCED STRATIFICATION OF PEOPLE WITH DEPRESSION BASED ON INFLAMMATION 
Organisation San Raffaele Hospital
Country Italy 
Sector Hospitals 
PI Contribution A consotium brought together to apply to the Wellcome trust for a programme of research
Collaborator Contribution They are all workpackage leaders, co-applicants or collaborators.
Impact Successful award of the grant
Start Year 2023
 
Description ASPIRE - ADVANCED STRATIFICATION OF PEOPLE WITH DEPRESSION BASED ON INFLAMMATION 
Organisation University Hospital of Münster
Country Germany 
Sector Hospitals 
PI Contribution A consotium brought together to apply to the Wellcome trust for a programme of research
Collaborator Contribution They are all workpackage leaders, co-applicants or collaborators.
Impact Successful award of the grant
Start Year 2023
 
Description ASPIRE - ADVANCED STRATIFICATION OF PEOPLE WITH DEPRESSION BASED ON INFLAMMATION 
Organisation University of Antwerp
Country Belgium 
Sector Academic/University 
PI Contribution A consotium brought together to apply to the Wellcome trust for a programme of research
Collaborator Contribution They are all workpackage leaders, co-applicants or collaborators.
Impact Successful award of the grant
Start Year 2023
 
Description ASPIRE - ADVANCED STRATIFICATION OF PEOPLE WITH DEPRESSION BASED ON INFLAMMATION 
Organisation University of Bordeaux
Country France 
Sector Academic/University 
PI Contribution A consotium brought together to apply to the Wellcome trust for a programme of research
Collaborator Contribution They are all workpackage leaders, co-applicants or collaborators.
Impact Successful award of the grant
Start Year 2023
 
Description ASPIRE - ADVANCED STRATIFICATION OF PEOPLE WITH DEPRESSION BASED ON INFLAMMATION 
Organisation University of Bristol
Country United Kingdom 
Sector Academic/University 
PI Contribution A consotium brought together to apply to the Wellcome trust for a programme of research
Collaborator Contribution They are all workpackage leaders, co-applicants or collaborators.
Impact Successful award of the grant
Start Year 2023
 
Description ASPIRE - ADVANCED STRATIFICATION OF PEOPLE WITH DEPRESSION BASED ON INFLAMMATION 
Organisation University of Cape Town
Country South Africa 
Sector Academic/University 
PI Contribution A consotium brought together to apply to the Wellcome trust for a programme of research
Collaborator Contribution They are all workpackage leaders, co-applicants or collaborators.
Impact Successful award of the grant
Start Year 2023
 
Description ASPIRE - ADVANCED STRATIFICATION OF PEOPLE WITH DEPRESSION BASED ON INFLAMMATION 
Organisation University of Milan
Country Italy 
Sector Academic/University 
PI Contribution A consotium brought together to apply to the Wellcome trust for a programme of research
Collaborator Contribution They are all workpackage leaders, co-applicants or collaborators.
Impact Successful award of the grant
Start Year 2023
 
Description Covid research network 
Organisation Guy's and St Thomas' NHS Foundation Trust
Country United Kingdom 
Sector Public 
PI Contribution We are leading a consortium of scientists interested in the molecular mechanisms underpinning the effects of COVID on the brain
Collaborator Contribution We have led our first submitted publication and our first grant submission
Impact 1) For submission to Molecular Psychiatry Neurogenesis is disrupted in human hippocampal progenitor cells upon exposure to serum samples from hospitalized COVID-19 patients with neurological symptoms Alessandra Borsini, PhD1*, Blair Merrick, MD2, Jonathan Edgeworth, PhD, MD3, Deepak Srivastava, PhD4,5, Anthony C. Vernon, PhD4,5, Gaia Nebbia, PhD, MD3, Sandrine Thuret, PhD4, Carmine M. Pariante, PhD, MD1 1 Stress, Psychiatry and Immunology Laboratory, Institute of Psychiatry, Psychology and Neuroscience, Department of Psychological Medicine, King's College London, UK 2 Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust, London, UK 3 School of Immunology and Microbial Sciences, Guy's and St Thomas' NHS Foundation Trust, London, UK 4 Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK 5MRC Centre for Neurodevelopmental Disorders, King's College London, UK 2) King's Together: Round 10 - Support for re-starting research and research careers post-COVID (NOT FUNDED): Gaining mechanistic insight "in vitro" on how hippocampal brain cells function isare disrupted upon exposure to serum from long-COVID-19 patients with neurological manifestations (neuro long-COVID-19) Role in project Name Faculty Department Position Joint Principal Investigator Carmine M. Pariante (F) Psychiatry, Psychology and Neuroscience Psychological Medicine Academic (Professor) Joint Principal Investigator Alessandra Borsini Psychiatry, Psychology and Neuroscience Psychological Medicine PDRA Joint Principal Investigator Tom Pollak Psychiatry, Psychology and Neuroscience Psychosis Studies Academic (Lecturer) Joint Principal Investigator Leonie Taams Life Sciences & Medicine Immunology, Infection & Inflammatory Disease Academic (Professor) Joint Principal Investigator Clare Brant Arts & Humanities English Language & Literature Academic (Professor) Joint Principal Investigator Anna Reading Arts & Humanities Culture, Media & Creative Industries Academic (Professor) CoI Sandrine Thuret Neuroscience Basic and Clinical Neuroscience Academic (Reader) CoI Tony Vernon Neuroscience Basic and Clinical Neuroscience Academic (Senior Lecturer) CoI Deepak Srivastava Neuroscience Basic and Clinical Neuroscience Academic (Reader) CoI Tim Nicolson Psychiatry, Psychology and Neuroscience Psychosis Studies Academic (Lecturer) CoI Ester Coutinho Neuroscience Clinical and Basic Neurosciences Research Fellow CoI Francesca Capon Life Sciences & Medicine Medical & Molecular Genetics Academic (Reader) CoI Beatrice Pembroke KCL Culture Team Not applicable Executive Director CoI Johanna Kieniewicz KCL Culture Team Not applicable Head of Education and Research Collaborations 3) - Rosetrees Trust - Borsini (PI) 01/02/2021-31/01/2022 £25,000 Effects of COVID-19 on the brain and gaining mechanistic insight "in vitro" - 1 hour/week
Start Year 2021
 
Description EU EARLYCAUSE 
Organisation University of Barcelona
Country Spain 
Sector Academic/University 
PI Contribution Karim Lekadir, PhD, is the Director of the Artificial Intelligence in Medicine Lab at the Universitat de Barcelona, and is the coordinator for the EU consortium EarlyCause H2020 project. I am the workpackage leader for the celular component, but the overal consortium aims to study the causative mechanisms linking early-life-stress to psycho-cardio-metabolic multi-morbidity
Collaborator Contribution Dr Kadir has led the application phase and contonue to succesfully lead the programme
Impact EU EARLYSTART 06/12/2019-05/12/2023 £391,175 research grant to KCL, Euro6M to the whole consortium
Start Year 2018
 
Description Immuno-NeuroPsychiatry Thematic Working Group 
Organisation European College of Neuropsychopharmacology (ECNP)
Country Netherlands 
Sector Charity/Non Profit 
PI Contribution The TWG on "Immuno-NeuroPsychiatry" comprise internationally recognized clinical centers particularly helpful for the development of data bases, pathophysiological and therapeutic studies in humans. They will be completed by the implementation of research groups using laboratory animal models to perform high-level translational research projects, enabling to substantially improve mechanistic and functional knowledge about the exact nature of the relationships of inflammatory state with relevant clinical dimensions, treatment resistance and therefore promote appropriate pharmacological interventions. I am a senior member of this initiative, andmany members of my research group also are part of this.
Collaborator Contribution ECNP has led the process bringing the many scientist together and offered infrastructure support for the relevant publications, including dissemination and press support.
Impact De Picker LJ, Dias MC, Benros ME, Vai B, Branchi I, Benedetti F, Borsini A, Leza JC, Kärkkäinen H, Männikkö M, Pariante CM, Güngör ES, Szczegielniak A, Tamouza R, van der Markt A, Fusar-Poli P, Beezhold J, Leboyer M. Severe mental illness and European COVID-19 vaccination strategies. Lancet Psychiatry. 2021 Feb 17:S2215-0366(21)00046-8. doi: 10.1016/S2215-0366(21)00046-8. Epub ahead of print. Erratum in: Lancet Psychiatry. 2021 Feb 25;: PMID: 33609450; PMCID: PMC7906735. De Picker LJ, Yolken R, Benedetti F, Borsini A, Branchi I, Fusar-Poli P, Carlos Leza J, Pariante C, Pollak T, Tamouza R, Vai B, Vernon AC, Benros ME, Leboyer M; ECNP Immuno-NeuroPsychiatry TWG. Viewpoint | European COVID-19 exit strategy for people with severe mental disorders: Too little, but not yet too late. Brain Behav Immun. 2021 Jan 23:S0889-1591(21)00012-X. doi: 10.1016/j.bbi.2021.01.008. Epub ahead of print. PMID: 33493625. Branchi I, Poggini S, Capuron L, Benedetti F, Poletti S, Tamouza R, Drexhage HA, Penninx BWJH, Pariante CM; European College of Neuropsychopharmacology (ECNP) ImmunoNeuroPsychiatry Thematic Working Group and Marion Leboyer. Brain- immune crosstalk in the treatment of major depressive disorder. Eur Neuropsychopharmacol. 2020 Dec 29:S0924-977X(20)30968-8. doi: 10.1016/j.euroneuro.2020.11.016. Epub ahead of print. PMID: 33386229.
Start Year 2019
 
Description Janssen Pharmaceuticals 
Organisation Johnson & Johnson
Department Janssen Pharmaceuticals
Country United States 
Sector Private 
PI Contribution A joint academic-pharma collaboration that has brought approximately £680,000 in research funding
Collaborator Contribution Shared academic leadership and full funding of research programma
Impact - a fully funded research programme on depression and inflammation - additional grant applications to MRC and the Wellcome
Start Year 2012
 
Description MRC Immunopsychiatry Consortium 
Organisation GlaxoSmithKline (GSK)
Department Psychiatry (GSK)
Country United Kingdom 
Sector Private 
PI Contribution Design of studies, execution of studies and experiments
Collaborator Contribution Funding of studies, contribution to research strategy and design
Impact Data exchange, publications (in preparation)
Start Year 2014
 
Description MRC Immunopsychiatry Consortium 
Organisation Medical Research Council (MRC)
Country United Kingdom 
Sector Public 
PI Contribution Design of studies, execution of studies and experiments
Collaborator Contribution Funding of studies, contribution to research strategy and design
Impact Data exchange, publications (in preparation)
Start Year 2014
 
Description Wellcome Trust Neuroimmunology Consortium 
Organisation H. Lundbeck A/S
Department Neuroscience; Lundbeck
Country Denmark 
Sector Private 
PI Contribution A research consortium; we recruit and select patients and deliver research
Collaborator Contribution They participate to the research strategy
Impact Data collection, publications (all still in preparation), novel potential targets for antidepressants discovery
Start Year 2014
 
Description Wellcome Trust Neuroimmunology Consortium 
Organisation Johnson & Johnson
Country United States 
Sector Private 
PI Contribution A research consortium; we recruit and select patients and deliver research
Collaborator Contribution They participate to the research strategy
Impact Data collection, publications (all still in preparation), novel potential targets for antidepressants discovery
Start Year 2014
 
Description Wellcome Trust Neuroimmunology Consortium 
Organisation Pfizer Ltd
Country United Kingdom 
Sector Private 
PI Contribution A research consortium; we recruit and select patients and deliver research
Collaborator Contribution They participate to the research strategy
Impact Data collection, publications (all still in preparation), novel potential targets for antidepressants discovery
Start Year 2014
 
Description Wellcome Trust Neuroimmunology Consortium 
Organisation Wellcome Trust
Department Wellcome Trust Strategic Award
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution A research consortium; we recruit and select patients and deliver research
Collaborator Contribution They participate to the research strategy
Impact Data collection, publications (all still in preparation), novel potential targets for antidepressants discovery
Start Year 2014
 
Title Clinical Trial with Minocycline in depressed patients with high-inflammation 
Description The trial has been completed and publiished as Nettis MA, Lombardo G, Hastings C, Zajkowska Z, Mariani N, Nikkheslat N, Worrell C, Enache D, McLaughlin A, Kose M, Sforzini L, Bogdanova A, Cleare A, Young AH, Pariante CM, Mondelli V. Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial. Neuropsychopharmacology. 2021 Jan 28. doi: 10.1038/s41386-020-00948-6. Epub ahead of print. PMID: 33504955. This study aimed to investigate the role of baseline levels of peripheral inflammation when testing the efficacy of antidepressant augmentation with minocycline in patients with treatment-resistant depression. We conducted a 4-week, placebo-controlled, randomised clinical trial of minocycline (200 mg/day) added to antidepressant treatment in 39 patients selected for elevated levels of serum C-reactive protein (CRP = 1 mg/L), n = 18 randomised to minocycline (M) and n = 21 to placebo (P). The main outcome was the change in Hamilton Depression Rating Scale (HAM-D-17) score from baseline to week 4, expressed both as mean and as full or partial response, in the overall sample and after further stratification for baseline CRP=3 mg/L. Secondary outcomes included changes in other clinical and inflammatory measures. Changes in HAM-D-17 scores and the proportion of partial responders did not differ between study arms. After stratification for CRP levels <3 mg/L (CRP-) or =3 mg/L (CRP+), CRP+/M patients showed the largest changes in HAM-D-17 scores (mean ± SD = 12.00 ± 6.45) compared with CRP-/M (2.42 ± 3.20, p < 0.001), CRP+/P (3.50 ± 4.34, p = 0.003) and CRP-/P (2.11 ± 3.26, p = 0.006) patients, and the largest proportion (83.3%, p = 0.04) of partial treatment response at week 4. The threshold point for baseline CRP to distinguish responders from non-responders to minocycline was 2.8 mg/L. Responders to minocycline had higher baseline IL-6 concentrations than non-responders (p = 0.03); IFN? was significantly reduced after treatment with minocycline compared with placebo (p = 0.03). Our data show some evidence of efficacy of add-on treatment with minocycline in MDD patients but only in those with low-grade inflammation defined as CRP =3 mg/L. 
Type Therapeutic Intervention - Drug
Current Stage Of Development Early clinical assessment
Year Development Stage Completed 2021
Development Status Closed
Clinical Trial? Yes
Impact This is the first trial selecting depressed patients based on a blood-test, hence the first attempt to bring personalised medicine into psychiatry. The paper has just been published and so impact is ongoing. 
URL https://pubmed.ncbi.nlm.nih.gov/33504955/
 
Description A follow-up interview after one year of pandemic, for the Science Weekly Guardian Podcast 
Form Of Engagement Activity A broadcast e.g. TV/radio/film/podcast (other than news/press)
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Ian Sample is joined again by Prof Carmine Pariante to discuss pandemic burnout and how to look after our mental health over the coming months
Year(s) Of Engagement Activity 2021
URL https://www.theguardian.com/science/audio/2021/mar/02/covid-19-why-are-we-feeling-burnt-out
 
Description An feature article in The New Humanist 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact A feature article describing pros and cons of antidepressants
Year(s) Of Engagement Activity 2023
URL https://newhumanist.org.uk/articles/6217/the-drugs-do-work
 
Description Antidepressants may not be perfect, but they DO save lives: Expert reveals how life-changing the drug can be when used in the right way 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact Professor Carmine Pariante has treated thousands of patients with depression Despite expert claims the pills have devastating side-effects, he stands by them
They work when used correctly, especially alongside psychological therapy

Read more: http://www.dailymail.co.uk/health/article-4243156/Antidepressants-not-perfect-save-lives.html#ixzz4awYvDP2Q
Year(s) Of Engagement Activity 2017
URL http://www.dailymail.co.uk/health/article-4243156/Antidepressants-not-perfect-save-lives.html
 
Description Article for The Independent 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact An opinion piece defending the safe use of antidepressants. As a psychiatrist, I know that Johann Hari is wrong to cast doubt on antidepressants
Suggesting that prescribing antidepressants to a patient who suffers from clinical depression is the equivalent of treating them as a 'machine with malfunctioning parts' is wrong, unhelpful and even dangerous

Carmine Pariante Wednesday 10 January 2018 14:00 GMT
Year(s) Of Engagement Activity 2018
URL http://www.independent.co.uk/voices/johann-hari-depression-anti-depressants-psychiatrists-pills-ther...
 
Description BBC Radio 4 - Phantoms in the Brain, an interview on inflammation and mental health 
Form Of Engagement Activity A broadcast e.g. TV/radio/film/podcast (other than news/press)
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact BBC Radio 4 - Phantoms in the Brain, an interview on inflammation and mental health -
Year(s) Of Engagement Activity 2022
URL https://tr.ee/aobhoiaxi6
 
Description Blog on the Huffington Post 
Form Of Engagement Activity Engagement focused website, blog or social media channel
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact A regular blog entry that I have on the Huffington Post on topics of mental health
Year(s) Of Engagement Activity 2012,2015,2016,2017
URL http://www.huffingtonpost.co.uk/author/carmine-pariante
 
Description Cheltenham Science festival 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? Yes
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact Many questions and subsequent emails

I was reached by journalists for further interviews
Year(s) Of Engagement Activity 2012
 
Description Daily Mail 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact Interview of perinatal depression

Attracted public interest
Year(s) Of Engagement Activity 2010
 
Description Immune reactions to severe Covid may trigger brain problems, study finds 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Interview to the Guardian related to one of my papers, Neurogenesis is disrupted in human hippocampal progenitor cells upon exposure to serum samples from hospitalized COVID-19 patients with neurological symptoms, https://www.nature.com/articles/s41380-022-01741-1
Year(s) Of Engagement Activity 2022
URL https://www.theguardian.com/world/2022/oct/05/immune-reactions-to-severe-covid-may-trigger-brain-pro...
 
Description Inspire the Mind - a new online publication on mental health 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact InSPIre the Mind is new online publication directed by Carmine Pariante. It will bring the point of view of a group of clinicians and researchers working in mental health. In this new publication, we want to complement people's accounts by discussing the clinical and the scientific evidence underpinning these personal experiences, while also sharing with the readers our research, our clinical work, and or our cultural and societal considerations. We are the members of the Stress, Psychiatry and Immunology (SPI) Lab at the Institute of Psychiatry, Psychology and Neuroscience, at King' College London, and these are our stories.

So far, the website has been visited more than 100,000 times
Year(s) Of Engagement Activity 2019,2020,2021
URL http://www.inspirethemind.org
 
Description Interview for BBC Radio 4 Programme 
Form Of Engagement Activity A broadcast e.g. TV/radio/film/podcast (other than news/press)
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact BBC health reporter James Gallagher explores the increasing body of evidence that a dysfunctional immune system is responsible for the depression or psychotic illness experienced by hundreds of thousands, perhaps millions, of people in the UK. James talks to the psychiatrists investigating this new understanding of mental illness and to people who may benefit from treatments aimed at the immune systems rather than their brain cells.

"I believe this is one of the strongest discoveries in psychiatry in the last twenty years", says Professor Carmine Pariante of his and other research on the immune system and depression. "It allows us to understand depression no longer as just a disorder of the mind and not even a disorder of the brain, but a disorder of the whole body. It shifts conceptually what we understand about depression."

James also talks to New York journalist Susannah Cahalan. She began to experience paranoid delusions and florid hallucinations when her immune system made damaging antibodies against part of the molecular circuitry in her brain. Treatment to eliminate the antibodies prevented her committal to psychiatric hospital. Psychiatrist Professor Belinda Lennox at the University of Oxford says she has evidence that a significant proportion of people presenting for the first time with psychotic symptoms are victims of a similar autoimmune problem.

Producer: Rachael Buchanan and Andrew Luck-Baker.
Year(s) Of Engagement Activity 2016
URL http://www.bbc.co.uk/programmes/b07pj2pw
 
Description Interview for The Guardian Science Weekly Podcast on the Impact of the pandemic on mental health 
Form Of Engagement Activity A broadcast e.g. TV/radio/film/podcast (other than news/press)
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact As the lockdown in the UK looks set to continue, Ian Sample speaks to Prof Carmine Pariante about the physiological and psychological effects of social isolation.
Year(s) Of Engagement Activity 2020
URL https://www.theguardian.com/science/audio/2020/apr/15/covid-19-how-can-social-isolation-affect-us-po...
 
Description Interview on the Daily Mail on my research on CFS/ME 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Journalist Jo MacFarlane interviewed me on my research on CFS/ME and its relevance to Long Covid
Year(s) Of Engagement Activity 2020
URL https://www.dailymail.co.uk/health/article-8303305/Will-Covid-19-survivors-face-lifetime-illness-lik...
 
Description Interview with New York Times on my research on CFS/ME 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Journalist Moises Velasquez-Manoff interviewed me on my research on CFS/ME and its relevance to long-covid
Year(s) Of Engagement Activity 2021
URL https://www.nytimes.com/2021/01/21/magazine/covid-aftereffects.html
 
Description Interview with Vice.com on my research on CFS/ME 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Journalist Nichola Kelly interviewed me on my research on CFS/ME and its relevance to Long Covid
Year(s) Of Engagement Activity 2020
URL https://www.vice.com/en/article/z3evby/young-people-with-coronavirus-symptoms-relapse
 
Description Laboratory Facebook account 
Form Of Engagement Activity Engagement focused website, blog or social media channel
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact This is the Facebook page of the Stress, Psychiatry and Immunology Laboratory; The Stress, Psychiatry and Immunology Laboratory (SPI Lab) is an academic research laboratory within King's College London, led by Professor Carmine Pariante. Our team is made up of clinicians, research and postgraduate students who work across a range of clinical settings. Some of the disorders we investigate include depression, first-episode psychosis, women in the perinatal period (and their infants), individuals with history of trauma, and patients with inflammation-related medical disorders such as viral hepatitis and chronic fatigue. We place a strong emphasis on biological and molecular research relevant to mental health, using biological samples derived from patient populations, experimental cellular and animal models.
Year(s) Of Engagement Activity 2015,2016,2017,2018,2019,2020,2021
URL https://www.facebook.com/SPILabKCL/
 
Description Marking #WorldMentalHealthDay with a European Patients' Podcast 
Form Of Engagement Activity A broadcast e.g. TV/radio/film/podcast (other than news/press)
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Patients, carers and/or patient groups
Results and Impact European Patients' Podcast: The Voice of Patients in Europe
By eupatientsforum
The European Patients' Podcast is your source for conversation and news around the world of patient advocacy and empowerment. This podcast is brought to you by the European Patients' Forum, the leading voice of patient organisations in Europe with 77 members across the continent.

Marking #WorldMentalHealthDay with a European Patients' Podcast
Year(s) Of Engagement Activity 2022
URL https://anchor.fm/eupatients/episodes/Marking-WorldMentalHealthDay-with-the-EU-PEARL-project-e1ossck...
 
Description Personal blog on the Huffington Post 
Form Of Engagement Activity Engagement focused website, blog or social media channel
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact regular entry blogs on topics related to mental health
Year(s) Of Engagement Activity 2015,2016
URL http://www.huffingtonpost.co.uk/carmine-pariante/
 
Description Personal twitter account 
Form Of Engagement Activity Engagement focused website, blog or social media channel
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact This is my personal twitter account: Carmine M. Pariante @ParianteSPILab - Psychiatrist and researcher @SPILabKCL. Writer & Editor @inspirethemind_ @BrainBehavImm @BBI_Health. President @ISPNE. Creativity. Social justice. And kung fu.
Year(s) Of Engagement Activity 2015,2016,2017,2018,2019,2020,2021
URL https://twitter.com/ParianteSPILab
 
Description Plenary Lecture at the Conference of Forensic Psychiatry of the Royal College of Psychiatrists 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact A plenary lecture on my research on depression and inflammation
Year(s) Of Engagement Activity 2017
 
Description Plenary Lecture at the Italian Society for Psychopathology 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact A plenary lecture on my research on depression and the immune system
Year(s) Of Engagement Activity 2017
 
Description Press conference 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Media (as a channel to the public)
Results and Impact Press conference associated with a symposium on depression

Private interviews with a radio, description on news websites
Year(s) Of Engagement Activity 2009
 
Description Salon London public event on stress and mental health 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact More than 100 people attended this public event as part of Salon London, an established series of cultural events in London.
Year(s) Of Engagement Activity 2020
URL https://www.salon-london.com/event/the-science-of-stress
 
Description Symposium at the Royal College of Psychiatrists 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact S33 Predicting response to antidepressants: Is it possible? Wednesday 1st of July 2015
Chair: Dr Hamish McAllister-Williams, Newcastle University

HPA axis and inflammatory cytokines *Professor Carmine Pariante, Institute of Psychiatry, London

Cognition and emotional processing Professor Catherine Harmer, University of Oxford EEG variables
Dr Hamish McAllister-Williams, Newcastle University


S54 Inflammation & Mental Health: An overview of perinatal and later life infection/inflammation on risk for common mental illnesses - - Thursday 2nd of July
Chair: Prof Hugo Critchley, Brighton & Sussex Medical School

Early-life infection alters glial function and increases susceptibility to cognitive and neuropsychiatric disorders including schizophrenia and
autism
Dr Staci Bilbo, Duke University

Can blood and brain MRI biomarkers be used to identify patients most likely to benefit from 'anti-inflammatory' treatments?
Dr Neil Harrison, University of Sussex

Update on the current evidence supporting a role for 'anti-inflammatory' agents in the management of treatment resistant depression *Professor Carmine Pariante, Kings College London
Year(s) Of Engagement Activity 2015
 
Description Visit of HRH The Duchess of Cambridge to Professor Pariante's laboratory 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact The Duchess of Cambridge visits King's College London's IoPPN and the Mother and Baby Unit at Bethlem Royal Hospital

The Duchess of Cambridge visited Professor Pariante's laboratory at the Maurice Wohl Clinical Neuroscience Institute at King's College London to find out more about the Institute of Psychiatry, Psychology & Neuroscience's (IoPPN) pioneering 'bench to bedside' mental health research and to meet leading scientists in the area. The Duchess continued to the Mother and Baby Unit, Royal Bethlem Hospital, South London and Maudsley NHS Foundation Trust, to meet clinicians and patients.
Year(s) Of Engagement Activity 2018
URL https://www.kcl.ac.uk/ioppn/news/records/2018/january/duchess-of-cambridge-visits-kings-college-lond...